Download App
Current Complaints | Help Center| Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Gaudium IVF and Women Health Ltd (GAUDIUMIVF)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544709 NSE: GAUDIUMIVF Hospital & Healthcare Services | Small Cap | Gaudium IVF & Women Share Price

₹111.10 -2.90 (-2.54%)

As on 30-Sep'26 16:59

Gaudium IVF and Women Health Ltd (GAUDIUMIVF)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544709 NSE: GAUDIUMIVF Hospital & Healthcare Services | Small Cap | Gaudium IVF & Women Share Price

₹111.10 -2.90 (-2.54%)

As on 30-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹830 Cr.
Current Price
₹111.1
52-Week Low / High
₹70 / 164
TTM EPS
₹3.4
TTM Sales
₹104 Cr.
Book Value per Share
₹21.2
P/E Ratio
33.92
Lower than its 5-year historical median
Industry PE
98.2
Price to Book (P/B)
5.39
Lower than its 5-year historical median
Price to Sales (P/S)
7.95
Lower than its 5-year historical median
EV/EBITDA
21.88
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
24.66%
Outperforms industry median
Return on Capital Employed (ROCE)
29.95%
Outperforms industry median
Return on Assets (ROA)
16.61%
Operating Profit Margin
36.5%
Net Profit Margin
23.47%
Gross Profit Margin
33.3%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
21.32%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
31.75%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
27.69%
Asset Quality
Promoter Holding
71.29%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹118 Cr.
Equity
₹36.4 Cr.
Face Value
₹5
All Time Low / High
₹69.50 / 163.70

Gaudium IVF and Women Health stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Somewhat Good
Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is Gaudium IVF and Women Health Ltd a good quality company?
Gaudium IVF and Women Health Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Gaudium IVF and Women Health Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Gaudium IVF and Women Health Ltd vs industry peers?
Gaudium IVF and Women Health Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Gaudium IVF and Women Health Ltd?
Promoters hold 71.29% of the Gaudium IVF and Women Health Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Gaudium IVF and Women Health Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gaudium IVF and Women Health Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ82.7%76.5%45.4%49.3%28.1%-
Value Creation
Index ⓘ		4.94.52.22.51.0-

Growth Parameters ⓘ
Sales ⓘ36.54445.95971.672
Sales YoY Gr.-20.5%4.4%28.4%21.3%-
Adj EPS ⓘ1.52.21.633.13.1
YoY Gr.-46%-25%87.7%0.7%-
BVPS (₹) ⓘ1.63.74.37.420.520.7
Adj Net
Profit ⓘ		9.113.39.918.622.322
Cash Flow from Ops. ⓘ0243.58.47.3-
Debt/CF from Ops. ⓘ00.44.52.22.9-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA17.6%21.3%
Adj EPS ⓘNANA12.3%0.7%
BVPSⓘNANA76.7%177.2%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ		95.181.940.151.722.914.8
Op. Profit
Mgn % ⓘ		37.844.941.147.648.737.6
Net Profit
Mgn % ⓘ		24.930.121.631.631.131.1
Debt to
Equity ⓘ		0.60.40.60.40.1-
Working Cap
Days ⓘ		0759119547461
Cash Conv.
Cycle ⓘ		0134910614733

Valuation of Gaudium IVF & Women - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Sales37444871104
Operating Expenses ⓘ + 2324284266
Manufacturing Costs85669
Material Costs4551534
Employee Cost 56678
Other Costs ⓘ 68111315
Operating Profit ⓘ 1420192938
Operating Profit Margin (%) 37.0%45.7%40.6%40.8%36.5%
Other Income ⓘ + 00001
Exceptional Items ⓘ 00000
Interest ⓘ 10124
Depreciation ⓘ 11223
Profit Before Tax ⓘ 1218172532
Tax ⓘ 35668
Profit After Tax 914101924
PAT Margin (%) 24.2%30.6%21.5%27.1%23.5%
Adjusted EPS (₹)1.42.21.73.13.4
Dividend Payout Ratio (%)0%47%0%0%0%
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 9232746152
Share Capital ⓘ 0.990.990.9930.7036.39
Reserves ⓘ 8222616116
Debt +610161923
Long Term Debt22220
Short Term Debt48141723
Minority Interest00000
Trade Payables1111412
Others Liabilities ⓘ 1381612
Total Liabilities ⓘ 18375195200

Fixed Assets

Net Fixed Assets ⓘ +418191818
Gross Block719222224
Accumulated Depreciation31447
CWIP ⓘ 000712
Investments ⓘ 00055
Inventories01274
Trade Receivables61143353
Cash Equivalents 2151279
Others Assets ⓘ 5151799
Total Assets ⓘ 18375195200
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + -124397
PBT ⓘ 1218172532
Adjustment ⓘ 12346
Changes in Working Capital ⓘ -129-14-16-19
Tax Paid ⓘ -3-5-2-5-12
Cash Flow From Investing Activity ⓘ + -1-16-5-15-88
Capex -1-15-3-9-2
Net Investments 0-0-0-5-81
Others ⓘ 00-2-1-4
Cash Flow From Financing Activity ⓘ + 35-1282
Net Proceeds from Shares ⓘ 000090
Net Proceeds from Borrowing ⓘ 0-0-0-016
Interest Paid ⓘ -0-0-1-1-3
Dividend Paid ⓘ 00-600
Others ⓘ 3663-21
Net Cash Flow ⓘ 013-3-52
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)94.9984.4741.552.3424.66
ROCE (%)82.3978.7446.6550.1629.95
Asset Turnover Ratio2.081.631.090.970.71
PAT to CFO Conversion(x)-0.111.710.30.470.29
Working Capital Days
Receivable Days64.9030.5055.30119.90150.80
Inventory Days3.407.6013.7024.1018.80
Payable Days114.1087.5072.30181.20143.60

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gaudium IVF and Women Health Ltd FAQs

The current trading price of Gaudium IVF & Women on 30-Sep-2026 16:59 is ₹111.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Sep-2026 the market cap of Gaudium IVF & Women stood at ₹829.8 Cr

The latest P/E ratio of Gaudium IVF & Women as of 29-Sep-2026 is 37.23.

The latest P/B ratio of Gaudium IVF & Women as of 29-Sep-2026 is 5.50.

The 52-week high of Gaudium IVF & Women is ₹163.7 and the 52-week low is ₹69.50.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gaudium IVF & Women is ₹71.58 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gaudium IVF and Women Health Ltd is a average quality company.

The key valuation ratios of Gaudium IVF and Women Health Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gaudium IVF and Women Health Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health was originally incorporated in the name of ‘Gaudium IVF and Women Health Private Limited’ as a private limited company on March 24, 2015. Subsequently, the company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the shareholders held on September 28, 2024 and consequently, the name of the company was changed to ‘Gaudium IVF and Women Health Limited’.

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

The company offers a complete array of specialized fertility and reproductive health services. Its advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all its treatments are carefully designed to address a variety of infertility challenges for both male and female. The company also offers comprehensive gynaecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.

Business area of the company 

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

Services of the company

Fertility Treatment

  • IVF treatment, or in vitro fertilization
  • Intrauterine Insemination (IUI)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Polycystic Ovarian Syndrome (PCOS), also known as polycystic ovarian disease (PCOD)
  • Male Infertility
  • Endometriosis Treatment
  • Ovulation Induction (OI)
  • Laser Assisted Embryo Implantation
  • Infertility Surgeries
  • Surrogacy

Hospital Facility

Pharmacy service

Awards, accreditations and recognition 

  • 2016: Asia's Greatest Brand.
  • 2018: Symbol of Brand Excellence Award.
  • 2019: India Best Practices Award- IVF Chain Company of the Year.
  • 2022: Highly Prestigious Quality Choice Award.
  • 2023: Holistic Healthcare Brand Leader of the Year.

History and milestones

  • 2015: Incorporation of the company.
  • 2019: The company started Gaudium Hospital.
  • 2021: Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna: Janakpuri Center (opened in 2009), Greater Kailash Center (opened in 2016), Patna Center (opened in 2019).
  • 2021: The company started Mumbai Center (Maharashtra).
  • 2023: Acquired Gaudium Brand.
  • 2023: Acquired 100% shares of Gaudium International Private Limited.
  • 2023: Acquired Gaudium Bawa Ludhiana Center.
  • 2023: The company started Bangalore Centre (Karnataka).
  • 2024: The company started Srinagar Centre (Jammu & Kashmir).
  • 2024: Conversion of company from Private to Public.

You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now